References
- Mucenski ML, Taylor BA, Ihle JN, et al. Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol Cell Biol. 1988; 8(1):301–308. doi:https://doi.org/10.1128/MCB.8.1.301.
- Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, Ihle JN. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell. 1988; 54(6):831–840. doi:https://doi.org/10.1016/S0092-8674(88)91175-0.
- Laricchia-Robbio L, Nucifora G. Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1. Blood Cells Mol Dis. 2008; 40(2):141–147. doi:https://doi.org/10.1016/j.bcmd.2007.07.012.
- Kataoka K, Sato T, Yoshimi A, et al. Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity. J Exp Med. 2011; 208(12):2403–2416. doi:https://doi.org/10.1084/jem.20110447.
- Goyama S, Yamamoto G, Shimabe M, et al. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell. 2008; 3(2):207–220. doi:https://doi.org/10.1016/j.stem.2008.06.002.
- Hinai AA, Valk PJ. Review: Aberrant EVI1 expression in acute myeloid leukaemia. Br J Haematol. 2016; 172(6):870–878. doi:https://doi.org/10.1111/bjh.13898.
- Morishita K, Parganas E, William CL, et al. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc Natl Acad Sci USA. 1992; 89(9):3937–3941. doi:https://doi.org/10.1073/pnas.89.9.3937.
- Russell M, List A, Greenberg P, et al. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood. 1994; 84(4):1243–1248.
- Balgobind BV, Lugthart S, Hollink IH, et al. EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia. Leukemia. 2010; 24(5):942–949. doi:https://doi.org/10.1038/leu.2010.47.
- Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, van Putten WL, et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood. 2003; 101(3):837–845. doi:https://doi.org/10.1182/blood-2002-05-1459.
- Groschel S, Lugthart S, Schlenk RF, et al. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. JCO. 2010; 28(12):2101–2107. doi:https://doi.org/10.1200/JCO.2009.26.0646.
- Wu X, Wang H, Deng J, Zheng X, Ling Y, Gong Y. Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis. Ann Hematol. 2019; 98(11):2485–2496. doi:https://doi.org/10.1007/s00277-019-03774-z.
- Qin YZ, Zhao T, Zhu HH, et al. High EVI1 expression predicts poor outcomes in adult acute myeloid leukemia patients with intermediate cytogenetic risk receiving chemotherapy. Med Sci Monit. 2018; 24:758–767. doi:https://doi.org/10.12659/MSM.905903.
- Konantz M, Andre MC, Ebinger M, et al. EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia. Leukemia. 2013; 27(1):56–65. doi:https://doi.org/10.1038/leu.2012.211.
- Su G, Lian X, Tan D, et al. Aberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia. Leuk Lymphoma. 2015; 56(2):472–479. doi:https://doi.org/10.3109/10428194.2014.924118.
- De Weer A, Poppe B, Cauwelier B, et al. Screening for EVI1: Ectopic expression absent in T-cell acute lymphoblastic leukemia patients and cell lines. Cancer Gene Cytogenet. 2006; 171(1):79–80. doi:https://doi.org/10.1016/j.cancergencyto.2006.07.004.
- Vasyutina E, Boucas JM, Bloehdorn J, et al. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL. Leukemia. 2015; 29(10):2003–2014. doi:https://doi.org/10.1038/leu.2015.114.
- Stevens A, Hanson D, de Leonibus C, et al. EVI1 expression in childhood acute lymphoblastic leukaemia is not restricted to MLL and BCR/ABL rearrangements and is influenced by age. Blood Cancer J. 2014; 4(1):e179. doi:https://doi.org/10.1038/bcj.2013.76.
- Cui L, Li ZG, Chai YH, on behalf of the Chinese Children Leukemia Group(CCLG), et al. Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG-ALL 2008: the first nation-wide prospective multicenter study in china. Am J Hematol. 2018;93(7):913–920. doi:https://doi.org/10.1002/ajh.25124.
- Wang Y, Zeng HM, Zhang LP. ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol. Ital J Pediatr. 2018; 44(1):94. doi:https://doi.org/10.1186/s13052-018-0541-6.
- Qin YZ, Jiang Q, Xu LP, et al. The prognostic significance of Wilms’ tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia. Ann Hematol. 2019; 98(11):2551–2559. doi:https://doi.org/10.1007/s00277-019-03789-6.
- Beillard E, Pallisgaard N, van der Velden VH, et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program. Leukemia. 2003; 17(12):2474–2486. doi:https://doi.org/10.1038/sj.leu.2403136.
- Den Boer ML, van Slegtenhorst M, De Menezes RX, et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009; 10(2):125–134. doi:https://doi.org/10.1016/S1470-2045(08)70339-5.
- Dickstein J, Senyuk V, Premanand K, et al. Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome. Proc Natl Acad Sci USA. 2010; 107(21):9783–9788. doi:https://doi.org/10.1073/pnas.1004297107.
- Liu L, Wang J, Jiang Y, et al. EVI1 expression predicts outcome in higher-risk myelodysplastic syndrome patients. Leuk Lymphoma. 2018; 59(12):2929–2940. doi:https://doi.org/10.1080/10428194.2018.1459615.
- Daghistani M, Marin D, Khorashad JS, et al. EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors. Blood. 2010; 116(26):6014–6017. doi:https://doi.org/10.1182/blood-2010-01-264234.
- Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015; 373(16):1541–1552. doi:https://doi.org/10.1056/NEJMra1400972.
- Schrappe M, Hunger SP, Pui CH, et al. Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med. 2012; 366(15):1371–1381. doi:https://doi.org/10.1056/NEJMoa1110169.
- Ho PA, Alonzo TA, Gerbing RB, et al. High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: A report from the children’s oncology group. Br J Haematol. 2013;162(5):670–677. doi:https://doi.org/10.1111/bjh.12444.